Immuneering Corporation - Class A Common Stock (NQ:IMRX)
4.600
+0.060
(+1.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 24, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,294,552 |
| Open | 4.600 |
| Bid (Size) | 4.530 (100) |
| Ask (Size) | 4.600 (500) |
| Prev. Close | 4.540 |
| Today's Range | 4.515 - 4.650 |
| 52wk Range | 2.290 - 10.08 |
| Shares Outstanding | 25,938,064 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Friday's session: gap up and gap down stocks ↗
May 22, 2026
IMRX Stock Closed Over 20% Higher Today: Here’s Why ↗
January 07, 2026
Here are the top movers in Thursday's session. ↗
January 08, 2026
These stocks are gapping in today's session ↗
January 08, 2026
Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)
December 16, 2025
Frequently Asked Questions
Is Immuneering Corporation - Class A Common Stock publicly traded?
Yes, Immuneering Corporation - Class A Common Stock is publicly traded.
What exchange does Immuneering Corporation - Class A Common Stock trade on?
Immuneering Corporation - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immuneering Corporation - Class A Common Stock?
The ticker symbol for Immuneering Corporation - Class A Common Stock is IMRX on the Nasdaq Stock Market
What is the current price of Immuneering Corporation - Class A Common Stock?
The current price of Immuneering Corporation - Class A Common Stock is 4.600
When was Immuneering Corporation - Class A Common Stock last traded?
The last trade of Immuneering Corporation - Class A Common Stock was at 06/24/26 04:00 PM ET
What is the market capitalization of Immuneering Corporation - Class A Common Stock?
The market capitalization of Immuneering Corporation - Class A Common Stock is 119.32M
How many shares of Immuneering Corporation - Class A Common Stock are outstanding?
Immuneering Corporation - Class A Common Stock has 119M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.